Decalogue of guidelines for antibiotic use in critically ill patients;Decalogo de normas para la utilizacion de antibioticos en pacientes criticos

Medicina Intensiva

Volumn 24, Issue 2, 2000, Pages 69-77

  Alvarez Lerma F ^a   Palomar Martinez M ^b  

^a HOSPITAL DEL MAR   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Antibiotic use guidelines; Antibiotics; Critically ill patients; Intensive Medicine

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; CRITICAL ILLNESS; HUMAN; INSULIN RESISTANCE; MICROBIOLOGY; MULTIDRUG RESISTANCE; PRACTICE GUIDELINE; PRESCRIPTION;

EID: 0033925357     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-5691(00)79561-1     Document Type: Article

References (36)

1. Alvarez-Lerma F and ICU-Adquired Pneumonia Study Group Modification of empiric antibiotic treatment in patients with pneumonia acquired in intensive care unit. Intensive Care Med 1996; 22: 387-394.
2. Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111: 676-685.
3. Rello J, Gallego M, Mariscal D, Soñora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156: 196-200.
4. Kollef MH, Ward S. The influence of mini-BAL cultures on patients outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998; 113: 412-420.
5. Kollef MH, Vlasnik J, Sharpless L, Pasque C, Murphy D, Fraser V. Scheduled change of antibiotic classes. A strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156: 1 040-1 048.
6. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer J, Mariano N et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 14: 1.233-1.237.
7. Members of the American College of Chest Physicians and Society of Critical Care Medicine Consensus Conference Committee. Consensus Conference: Definitions for sepsis and organ failure and guidelines for use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.
8. The problem of sepsis- an expert report of the European Society of Intensive Care Medicine. Intensive Care Med 1994, 20:300-304.
9. Insausti J, Álvarez-Lerma F, de la Cal MA, Palomar M, Olaechea P and Study Group of ICU-Acquired Infection Surveillance. Antimicrobial therapy targeting ICU-acquired infections in Spain. Results of a collaborative study. 11th Annual Congress of the European Society of Intensive Care Medicine Stockholm. September 1998. Intensive Care Med 1998: 157 (suppl 1):57S (Abstract 493).
10. Vandenbroucke-Grauls CMJE, Vandenbroucke JP. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet 1991; 338: 859-862.
11. Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. Selective decontamination of the digestive tract trials. Collaborative Group. Br Med J 1993, 307: 525-532
12. Kollef MH. The role of selective digestive tract decontamination on mortality and respiratory tract infections. A metaanalysis. Chest 1994; 105: 1.101-1.108
13. D'Amico R, Pifferi S, Leonetti C, Torri V, Tinazzi A, Liberati A Effectiveness of antibiotic prophylaxis in critically ill adults patients: systematic review of randomised controlled trials. BMJ 1998; 316: 1.275-1.285.
14. Sirvent JM, Torres A, El-Ebiary M, Castro P, de Batlle J, Bonet A. Prospective effect of intravenously administered cefuroxime againts nosocomial pneumonia in patients with structural coma. Am J Respir Crit Care Med 1997; 155: 1.729-1.734.
15. Schardey HM, Joosten V, Finke V, Staubach KH, Schaver R, Heiss A et al. The prevention of anastomotic Leakage after total gastrectomy with local decontamination: a prospective, randomized, double-blind placebo-controlled multicentre trial. Ann Surg 1997; 225: 172-180.
16. Tetteroe GW, Wagenvoort JH, Castelein A, Tilanus HW, Ince C, Bruining HA. Selective decontamination to reduce gramnegative colonization and infections after aesophageal resection. Lancet 1990; 335: 704-707.
17. Nathens AB, Marshall JC. Selective decontamination of digestive tract in surgical patients. A systematic review of the evidence Arch Surg 1999; 134: 170-176
18. Luiten EST, Hop WCS, Lange JF, Bruining HA. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 1995; 222: 57-65.
19. McLelland P, Murray A, Yagood M, Van Saene HKF, Bone SM, Mostafa SM. Prevention of bacterial infections and sepsis in severe acute pancreatitis Ann R Coll Surg Engl 1992; 74: 329-334.
20. Jorda R, Parras F, Ibáñez J, Reina J, Bergadá J, Raurich JM. Diagnosis of nosocomial pneumonia in mechanically ventilated patients by the blind protected telescoping catheter. Intensive Care Med 1993; 19: 377-383.
21. Pugin J, Auckenthaler R, Mili A, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143: 1.121-1.129.
22. Washington JA, Brewer NS. Obtención de muestras para diagnóstico microbiológico. En: Perea EJ, ed. Entermedades infecciosas. Patogénesis y diagnóstico Barcelona: Salvat Editores SA, Barcelona, 1983: 125-152.
23. Domínguez JA, Manterola JM, Blavia R, Sopena N, Belda FJ, Padilla E, et al. Detection of Legionella pneumophila serogroup 1 antigen in nonconcentrated urine and urine concentrated by selective ultrafiltration J Clin Microbiol 1996; 34: 2.334-2.336.
24. Ribes JA, Limper AH, Espy MJ, Smith TF. PCR detection of Pneumocystis carinii in bronchoalveolar lavage specimens: analysis of sensitivity and specificity. J Clin Microbiol 1997; 35:830-835.
25. Sandhu GS, Kline BC, Stockman L, Roberts GD Molecular probes for diagnosis of fungal infections. J Clin Microbiol 1995; 33: 2.913-2.919
26. Fink MP, Snydman DR, Niederman MS, Leeper KV, Johnson RH, Heard SO, et al. Treatment of severe pneumonia in hospitalized patients: Results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with impipenem-cilastatin Antimicrob Agents Chemother 1994; 38: 547-557.
27. Silver D, Cohen I, Weinberg P. Recurrent Pseudomonas aerugmosa pneumonia in a Intensive Care Unit. Chest 1992;101: 194-198.
28. Johanson WG, Seidenfeld JJ, Gómez P, de los Santos R, Coalson J Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechanical ventilation. Am Rev Respir Dis 1988; 137: 259-264.
29. Domínguez-Gil Hurlé A. Farmacocinética de los antibióticos. En: Drobnic L, ed. Tratamiento antimicrobiano Madrid: Emisa, 1997: 51-74.
30. Smith CR, Lipsky JJ, Laskin LO, Hellmann DB, Mellits ED, Longstreth J, et al. Double blind comparison of the nephrotoxicity and auditory toxicity of gentamicyn and tobramycin. N Engl J Med 1980; 302: 1.106-1.109.
31. Slattery JT. A pharmacokinetic model independent for estimating dose required to give derived steady-state trough concentrations of drug in plasma. Clin Pharm 1993; 8: 105-110.
32. Álvarez Lerma F. Impacto de las resistencias bacterianas sobre la politica antibiótica. Med Intensiva 1998; 22: 17-23.
33. Kosmidis J, Koratzanis G. Emergence of resistant bacterial strains during treatment of infections in the respiratory tract. Scan J Infect Dis 1986; 49 (supp): 135-139
34. Dworzak DL, Pugsley MP, Sanders CL, Horowitt EA Emergence of resistance in Gram-negative bacteria during therapy with extended-spectrum cephalosporin. Eur J Clin Microbiol 1987; 6: 456-459
35. Chow JW. Enterobacter bacteriemia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115: 585-589.
36. a ed.): 690-705.